Almarzooqi Saeeda, Ahmad Al-Safi Rema'a, Fahad Al-Jassar Waleed, Akhter Syed M J, Chiab-Rassou Yamina, Albawardi Alia
Department of Pathology, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Acta Cytol. 2014;58(2):198-210. doi: 10.1159/000357966. Epub 2014 Feb 7.
Epithelioid trophoblastic tumor (ETT) is a rare gestational trophoblastic neoplasm of intermediate trophoblasts. It was first described by Shih and Kurman [Am J Surg Pathol 1998;22:1393-1403] who outlined its clinicopathologic characteristics in 14 cases, establishing it as a distinct entity of gestational trophoblastic tumors. It represents 1.39% of all gestational trophoblastic diseases. Most cases are reported in reproductive-age women following a prior gestation with a time interval between 2 weeks and 30 years. ETT is extremely rare in postmenopausal women. It is commonly misdiagnosed as a squamous cell carcinoma (SCC), poorly differentiated carcinoma or another gestational trophoblastic tumor. Limited data is available regarding its cytological features on Pap smears.
We report 2 cases of uterine ETT occurring in postmenopausal women. In both cases, an initial diagnosis of an SCC and a poorly differentiated carcinoma was rendered. We highlight the features of ETT helpful in differentiating it from other mimickers with emphasis on rarely reported cytological features of this neoplasm.
ETT is a rare tumor with characteristic cytological features, but is commonly confused with SCC. A high index of suspicion is needed to make the correct diagnosis or to raise the consideration of ETT, especially in cases with an increased β-human chorionic gonadotropin.
上皮样滋养细胞肿瘤(ETT)是一种罕见的中间型滋养细胞妊娠滋养细胞肿瘤。它最初由施和库尔曼[《美国外科病理学杂志》1998年;22:1393 - 1403]描述,他们概述了14例病例的临床病理特征,将其确立为妊娠滋养细胞肿瘤的一个独特实体。它占所有妊娠滋养细胞疾病的1.39%。大多数病例报道于有过先前妊娠的育龄妇女,时间间隔在2周和30年之间。ETT在绝经后妇女中极为罕见。它常被误诊为鳞状细胞癌(SCC)、低分化癌或其他妊娠滋养细胞肿瘤。关于其巴氏涂片的细胞学特征的数据有限。
我们报告2例发生在绝经后妇女的子宫ETT病例。在这两例中,最初诊断为SCC和低分化癌。我们强调有助于将ETT与其他相似肿瘤区分开来的特征,重点是该肿瘤很少报道的细胞学特征。
ETT是一种具有特征性细胞学特征的罕见肿瘤,但常与SCC混淆。需要高度怀疑指数才能做出正确诊断或提高对ETT的考虑,尤其是在β - 人绒毛膜促性腺激素升高的病例中。